Cyclophosphamide-induced tolerance in kidney transplantation avoids long-term immunosuppressive therapy

研究成果: ジャーナルへの寄稿評論記事

1 引用 (Scopus)

抄録

There has recently been remarkable progress in immunosuppressive agents, such as tacrolimus and cyclosporine. Therefore, the rate of organ establishment has improved in transplantation. However, immunosuppressive agents generally suppress the function of T cells. Thus, opportunistic infections, such as cytomegalovirus infection, are still a major problem in kidney transplantation. Induction of specific tolerance to avoid immunosuppressive drug therapy after kidney transplantation is considered as the ultimate goal of transplantation. Various factors induce tolerance that involves establishment of hematopoietic chimerism and various cell subsets. In particular, we have carried out various studies regarding the cyclophosphamide-induced tolerance system. Tolerance is induced after establishment of hematopoietic chimerism after donor bone marrow transplantation. At the clinical stage, kidney transplantation before administration of cyclophosphamide after transfusion of bone marrow to create hematopoietic chimera is considered to be one of the most successful protocols. Furthermore, recent studies have shown the involvement of multiple populations of immune cells in preserving immunological tolerance and promoting long-term renal grafts. The present review focuses on how cyclophosphamide and other immune factors induce tolerance in kidney transplantation.

元の言語英語
ページ(範囲)112-120
ページ数9
ジャーナルInternational Journal of Urology
25
発行部数2
DOI
出版物ステータス出版済み - 2 1 2018

Fingerprint

Immunosuppressive Agents
Kidney Transplantation
Cyclophosphamide
Chimerism
Transplantation
Opportunistic Infections
Cytomegalovirus Infections
Immunologic Factors
Tacrolimus
Therapeutics
Bone Marrow Transplantation
Cyclosporine
Bone Marrow
Transplants
Kidney
Drug Therapy
Population

All Science Journal Classification (ASJC) codes

  • Urology

これを引用

@article{90adc0c40bf24142a565c49d7f9e6a36,
title = "Cyclophosphamide-induced tolerance in kidney transplantation avoids long-term immunosuppressive therapy",
abstract = "There has recently been remarkable progress in immunosuppressive agents, such as tacrolimus and cyclosporine. Therefore, the rate of organ establishment has improved in transplantation. However, immunosuppressive agents generally suppress the function of T cells. Thus, opportunistic infections, such as cytomegalovirus infection, are still a major problem in kidney transplantation. Induction of specific tolerance to avoid immunosuppressive drug therapy after kidney transplantation is considered as the ultimate goal of transplantation. Various factors induce tolerance that involves establishment of hematopoietic chimerism and various cell subsets. In particular, we have carried out various studies regarding the cyclophosphamide-induced tolerance system. Tolerance is induced after establishment of hematopoietic chimerism after donor bone marrow transplantation. At the clinical stage, kidney transplantation before administration of cyclophosphamide after transfusion of bone marrow to create hematopoietic chimera is considered to be one of the most successful protocols. Furthermore, recent studies have shown the involvement of multiple populations of immune cells in preserving immunological tolerance and promoting long-term renal grafts. The present review focuses on how cyclophosphamide and other immune factors induce tolerance in kidney transplantation.",
author = "Ario Takeuchi and Koji Kato and Koichi Akashi and Masatoshi Eto",
year = "2018",
month = "2",
day = "1",
doi = "10.1111/iju.13474",
language = "English",
volume = "25",
pages = "112--120",
journal = "International Journal of Urology",
issn = "0919-8172",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Cyclophosphamide-induced tolerance in kidney transplantation avoids long-term immunosuppressive therapy

AU - Takeuchi, Ario

AU - Kato, Koji

AU - Akashi, Koichi

AU - Eto, Masatoshi

PY - 2018/2/1

Y1 - 2018/2/1

N2 - There has recently been remarkable progress in immunosuppressive agents, such as tacrolimus and cyclosporine. Therefore, the rate of organ establishment has improved in transplantation. However, immunosuppressive agents generally suppress the function of T cells. Thus, opportunistic infections, such as cytomegalovirus infection, are still a major problem in kidney transplantation. Induction of specific tolerance to avoid immunosuppressive drug therapy after kidney transplantation is considered as the ultimate goal of transplantation. Various factors induce tolerance that involves establishment of hematopoietic chimerism and various cell subsets. In particular, we have carried out various studies regarding the cyclophosphamide-induced tolerance system. Tolerance is induced after establishment of hematopoietic chimerism after donor bone marrow transplantation. At the clinical stage, kidney transplantation before administration of cyclophosphamide after transfusion of bone marrow to create hematopoietic chimera is considered to be one of the most successful protocols. Furthermore, recent studies have shown the involvement of multiple populations of immune cells in preserving immunological tolerance and promoting long-term renal grafts. The present review focuses on how cyclophosphamide and other immune factors induce tolerance in kidney transplantation.

AB - There has recently been remarkable progress in immunosuppressive agents, such as tacrolimus and cyclosporine. Therefore, the rate of organ establishment has improved in transplantation. However, immunosuppressive agents generally suppress the function of T cells. Thus, opportunistic infections, such as cytomegalovirus infection, are still a major problem in kidney transplantation. Induction of specific tolerance to avoid immunosuppressive drug therapy after kidney transplantation is considered as the ultimate goal of transplantation. Various factors induce tolerance that involves establishment of hematopoietic chimerism and various cell subsets. In particular, we have carried out various studies regarding the cyclophosphamide-induced tolerance system. Tolerance is induced after establishment of hematopoietic chimerism after donor bone marrow transplantation. At the clinical stage, kidney transplantation before administration of cyclophosphamide after transfusion of bone marrow to create hematopoietic chimera is considered to be one of the most successful protocols. Furthermore, recent studies have shown the involvement of multiple populations of immune cells in preserving immunological tolerance and promoting long-term renal grafts. The present review focuses on how cyclophosphamide and other immune factors induce tolerance in kidney transplantation.

UR - http://www.scopus.com/inward/record.url?scp=85032991910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032991910&partnerID=8YFLogxK

U2 - 10.1111/iju.13474

DO - 10.1111/iju.13474

M3 - Review article

C2 - 29105189

AN - SCOPUS:85032991910

VL - 25

SP - 112

EP - 120

JO - International Journal of Urology

JF - International Journal of Urology

SN - 0919-8172

IS - 2

ER -